22 min
TechNOW podcast: Breathable treatment for drug-resistant TB Australian Academy of Technology and Engineering
-
- Technology
COVID isn’t the only pandemic threat we face. The infectious disease that killed the most people in 2018 wasn’t malaria or HIV: it was tuberculosis.
Because of antibiotic resistance, a growing number of TB infections can’t be cured by current methods. Rising fever, chest-pain, coughing up blood – without new treatments, this ancient sickness could become a future crisis.
But what if we could treat antibiotic resistant TB with a new drug delivered straight into the lungs by an asthma-puffer style device?
Thanks to new technology developed by Associate Professor Charlotte Conn, her team at RMIT, and their collaborators in India, this dream cure could become a reality.
TechNOW is a podcast about Australian innovations that are shaping the future, thanks to the Global Connections fund – a project run by the Australian Academy of Technology and Engineering and supported by the Australian Government.
COVID isn’t the only pandemic threat we face. The infectious disease that killed the most people in 2018 wasn’t malaria or HIV: it was tuberculosis.
Because of antibiotic resistance, a growing number of TB infections can’t be cured by current methods. Rising fever, chest-pain, coughing up blood – without new treatments, this ancient sickness could become a future crisis.
But what if we could treat antibiotic resistant TB with a new drug delivered straight into the lungs by an asthma-puffer style device?
Thanks to new technology developed by Associate Professor Charlotte Conn, her team at RMIT, and their collaborators in India, this dream cure could become a reality.
TechNOW is a podcast about Australian innovations that are shaping the future, thanks to the Global Connections fund – a project run by the Australian Academy of Technology and Engineering and supported by the Australian Government.
22 min